首页> 外国专利> Novel component of von Hippel-Lindau tumor suppressor complex and SCF ubiquitin ligase

Novel component of von Hippel-Lindau tumor suppressor complex and SCF ubiquitin ligase

机译:von Hippel-Lindau抑癌复合物和SCF泛素连接酶的新成分

摘要

Rbx1, an evolutionarily conserved Cullin-interacting RING-H2 finger protein, has been discovered. Mammalian Rbx1 has been identified as a component of the CUL2-containing VHL complex. An Rbx1 homolog from S. cerevisiae has also been identified as a subunit and activator of the Cdc53-containing SCFCdc4 ubiquitin ligase required for ubiquitination of the cdk inhibitor Sicl and for the G1/S cell cycle transition in yeast, providing a link between the multiprotein VHL tumor suppressor complex and cellular ubiquitination. The Rbx1 protein acts as a cellular marker useful (1) in detecting a possible predisposition to certain carcinomas, (2) as a molecular target for treating those carcinomas therapeutically, (3) as a target for inhibition by drugs that manipulate the growth of cells, and (4) as a research tool to better understand the various complex mechanisms of cell ubiquitination, binding of certain activator proteins, fibronectin deposition and other aspects of the cellular division process.
机译:已发现Rbx1是一种进化上保守的与Cullin相互作用的RING-H2指蛋白。哺乳动物Rbx1已被确定为包含CUL2的VHL复合物的组成部分。来自啤酒酵母的Rbx1同源物也已被确定为cdk抑制剂SiCl的泛素化和酵母中G1 / S细胞周期转变所需的含Cdc53的SCF 泛素连接酶的亚基和激活剂,提供了一个联系VHL肿瘤抑制蛋白复合物与细胞泛素化之间的关系。 Rbx1蛋白是一种细胞标记,可用于(1)检测某些癌症的可能易感性;(2)作为治疗这些癌症的分子靶标;(3)作为抑制可操纵细胞生长的药物的靶标(4)作为研究工具,可以更好地了解细胞泛素化,某些激活蛋白的结合,纤连蛋白沉积以及细胞分裂过程的其他方面的各种复杂机制。

著录项

  • 公开/公告号AU769012B2

    专利类型

  • 公开/公告日2004-01-15

    原文格式PDF

  • 申请/专利权人 OKLAHOMA MEDICAL RESEARCH FOUNDATION;

    申请/专利号AU3378700A

  • 申请日2000-02-25

  • 分类号C07K1/00;A21C3/06;A21C3/08;B28B11/08;B28B21/48;B28B21/98;B29C53/00;B29C53/14;C07K14/00;C07K17/00;C12N5/00;C12N5/02;

  • 国家 AU

  • 入库时间 2022-08-21 23:01:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号